BIO Submits Amicus Brief in Sandoz Inc. v. Amgen Manufacutring Inc. and Amgen Manufacturing Ltd v. Sandoz Inc. (U.S. Supreme Court)
March 17, 2017
BIO submitted an amicus brief in Sandoz Inc. v. Amgen Inc. and Amgen Manufacturing Limited, as well as Amgen Inc. and Amgen Manufacturing Limited v. Sandoz Inc., at the Supreme Court of the United States.
As one of the leading proponents for the creation of a biosimilar approval pathway that also maintains incentives for innovation, BIO has a strong interest in the proper implementation of this statutory scheme by the courts.